Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Mass.-based Baystate Health to lay off 300 employees

Some 300 jobs will be eliminated at Springfield, Massachusetts-based Baystate Health, a decision the health system blamed in part of CMS's decision not to adjust one hospital’s mistakes that will cost facilities across the state millions in reduced Medicare reimbursements.

Ruling on Anthem-Cigna merger won’t come until Jan. 2017

Anthem can expect a ruling on the antitrust case against its proposed $54 billion takeover of Cigna sometime in January 2017, past the end-of-year timeframe it had requested.

Thumbnail

Economic reports show increases in healthcare spending, prices, new jobs over past year

Spending on healthcare throughout the U.S. grew 5.2 percent between June 2015 and June 2016, outpacing the 2.3 percent growth in the country’s gross domestic product (GDP), according to new economic reports from the Altarum Institute.

Texas Medical Center Innovation Institute kicks off third accelerator program

More than 11 medical device startups will head to Texas for the third installment of TMCx, an accelerator program that helps startups partner with industry experts that can help turn entrepreneur’s device concepts into reality.

Doctors dish out $32,000 a year for heath IT

Entering the digital age offers plenty of potential for the healthcare industry like more access to care and less waiting time. But with the pros comes the con—and the implementation of health IT costs doctors more than $32,000 per year, according to Forbes.

Trial for Aetna-Humana merger set to begin Dec. 5

The antitrust lawsuit against Aetna’s proposed acquisition of Humana won’t be settled as early as the insurer had hoped. A federal judge set a trial date of Dec. 5, with the decision to come after the year-end deadline to close the deal.

Editorial: Let the market control, reduce healthcare costs

Reducing the constantly increasing cost of healthcare is at the top of the list for anyone purchasing healthcare. The problem is finding where to cut these costs and figuring out why they have been increasing over the years.

The challenge of integrating healthcare's physical network with its digital one

The physical network of healthcare—hospitals, rehabilitation facilities, etc.—can be integrated with the digital network of EHRs and interoperability platforms to improve care and reduce costs.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.